4/A//SEC Filing
VANTAGEMED CORP 4/A
Accession 0001179110-07-008233
CIK 0001099531operating
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 6:55 PM ET
Size
8.6 KB
Accession
0001179110-07-008233
Insider Transaction Report
Form 4/AAmended
VANTAGEMED CORPVMDC
LOESCH LIESEL
Chief Financial Officer
Transactions
- Exercise/Conversion
vantagemed common stock
2007-04-18$0.20/sh+30,000$6,000→ 30,000 total - Disposition to Issuer
vantagemed common stock
2007-04-18$0.75/sh−30,000$22,500→ 0 total - Exercise/Conversion
option to purchase common stock
2007-04-18−30,000→ 0 totalExercise: $0.20From: 2003-01-02Exp: 2013-01-02→ vantagemed common stock (30,000 underlying)
Footnotes (1)
- [F1]This option is scheduled to vest and become exercisable with respect to 25% of the shares on the one year anniversary of the grant date. The balance of the shares will vest and become exercisable on a monthly basis for an additional 36 months.
Documents
Issuer
VANTAGEMED CORP
CIK 0001099531
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001099531
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 6:55 PM ET
- Size
- 8.6 KB